OBM Transplantation

(ISSN 2577-5820)

OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 7 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period). 

Current Issue: 2021  Archive: 2020 2019 2018 2017
Open Access Case Report

Pediatric Mixed Left Ventricular Non-Compaction and Restrictive Cardiomyopathy Bridged to Heart Transplant with Ventricular Assist

Adam K. Morrison 1, *, Robert J. Gajarski 2, Ashley Hodge 2, Sara Fitzgerald-Butt 3, Peter Baker 2, Patrick M. McConnell 2, Deipanjan Nandi 2

  1. Department of Pediatrics, Atrium Health, Levine Children’s Hospital, Charlotte, NC, USA
  2. Departments of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA
  3. Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA

Correspondence: Adam K. Morrison

Academic Editor: Yasuhiko Sugawara

Received: May 21, 2019 | Accepted: March 23, 2020 | Published: March 26, 2020

OBM Transplantation 2020, Volume 4, Issue 1, doi:10.21926/obm.transplant.2001105

Recommended citation: Morrison AK, Gajarski RJ, Hodge A, Fitzgerald-Butt S, Baker P, McConnell PM, Nandi D. Pediatric Mixed Left Ventricular Non-Compaction and Restrictive Cardiomyopathy Bridged to Heart Transplant with Ventricular Assist. OBM Transplantation 2020;4(1):7; doi:10.21926/obm.transplant.2001105.

© 2020 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.


Left ventricular noncompaction cardiomyopathy (LVNC) is a rare form of heritable cardiomyopathy with wide genotypic variability, numerous phenotypic variations, and a wide spectrum of clinical disease from asymptomatic to end stage heart failure. Here, we present a case of a 2-year-old boy who presented to their pediatrician with a cough as a first clinical sign of heart failure, rapidly progressing to severe heart failure. He was found to have mixed LVNC with a restrictive phenotype, a rare phenotype of this form of cardiomyopathy. Eventually, the patient was supported via mechanical circulation with a Berlin Heart EXCOR® ventricular assist device as bridge to successful cardiac transplantation. Genetic testing for inherited cardiomyopathies found a mutation in MYH7 (Arg369Gln), known to be associated with various forms of cardiomyopathy, but has not been reported in restrictive LVNC.

Graphical abstract

Click to view original image


Cardiomyopathy; transplant; genetics; cardiology; pediatric

1. Introduction

Left ventricular non-compaction (LVNC) is a form of cardiomyopathy characterized by the presence of prominent trabeculae, intertrabecular recesses, and myocardium that is characterized by two distinct layers of compacted and noncompacted myocardium [1]. It was first classified as a distinct form of cardiomyopathy in 2006 [2]. LVNC is a rare disease, with reported prevalence between 0.05 - 4 % in adults [3,4,5], although pediatric data suggests that LVNC is responsible for 9% of new cardiomyopathy diagnoses in children [6,7]. Clinical features of the disease range from asymptomatic to end stage heart failure. LVNC is also associated with a high mortality rate and is strongly associated with arrhythmias in children [8]. Restrictive LVNC is also rare, and is characterized by further findings left atrial or biatrial dilation with diastolic dysfunction with prognosis is similar to that of other forms of restrictive cardiomyopathy [9].

Here, we present a case of LVNC with restrictive physiology who was successfully bridged to cardiac transplantation via a Berlin Heart EXCOR® ventricular assist device. The patient was found to have a mutation in MYH7 (Arg369Gln). This specific mutation has not yet been reported in a patient with restrictive LVNC.

2. Case Report

A 23-month-old male with no previous medical history presented as a transfer from an outside facility with echocardiographic concerns for restrictive cardiomyopathy (RCM). He was initially seen by his PCP one week prior to transfer for a new cough. The cough persisted and the patient developed signs of respiratory distress, and the patient was taken to an outside facility where a chest film was concerning for cardiomegaly and he was found to have a gallop on exam. This led to an echocardiogram being performed and the referring physician had concerns for RCM. He was admitted to the cardiothoracic intensive care unit (CTICU) where a repeat echocardiogram was performed, which again showed signs of restrictive cardiomyopathy with massive left atrial enlargement, prominent left ventricular trabeculations concerning for LVNC (see Figure 1), mild to moderately depressed left ventricular (LV) systolic function with normal size (LVEDD 32mm, Z-score +0.1), mild to moderate mitral regurgitation, and mildly depressed right ventricular function. Beta-natriuretic peptide (BNP) on admission was 1,733 pg/mL (institutional ULN 60 pg/mL), peaking at 3323 pg/mL.

Due to concern for RCM, he underwent hemodynamic catheterization with pulmonary vasoreactivity testing, and endomyocardial biopsy. He was found to have a right pulmonary capillary wedge pressure of 27 mmHg, mean pulmonary artery pressures of 48 mmHg, right ventricular pressures of 58/15 mmHg, a pulmonary vascular resistance of 5.64 indexed Woods units, with a pulmonary vascular bed reactive to 100% oxygen. PVRi on 100% oxygen improved to 4.24 indexed Woods units. The pre-transplant endomyocardial biopsy showed myocyte hypertrophy and was negative for inflammation, interstitial fibrosis, small vessel disease and myocyte disarray. By cardiac MRI, he met criteria for LVNC with re-demonstration of severely dilated left atrium with moderate mitral regurgitation, normal left ventricular chamber size (LVEDV 86 mL/m2) with moderately depressed function and an LV ejection fraction of 36%. There was no evidence of delayed gadolinium enhancement. At this point, a working diagnosis of LVNC with a restrictive phenotype was instituted secondary to the left-sided structures being primarily involved.

Click to view original image

Figure 1 Image from the patient’s initial echocardiogram. This is an apical 4-chamber view showing massive left atrial dilation and heavily trabeculated left ventricular myocardium.

After returning from his cardiac catheterization, he was started on inotropic support with milrinone at 0.5 mcg/kg/min, diuretics were added, and he was continued on 100% FiO2 via nasal cannula. Given poor prognosis of symptomatic RCM, he was listed status 1A for cardiac transplantation on day 14 of admission. Over the next 3 months, he continued to decline, requiring escalating inotropic and respiratory support with worsen left ventricular dilation (LVEDD 39mm, Z-score +3.6). By day of admission 92, decision was made to place a Berlin Heart EXCOR left ventricular assist device (LVAD). Given his severe left atrial dilation, with smaller right atrium, it was possible to place the inflow cannula of the LVAD in the left atrium from an anterior approach, with outflow to the aorta. He was successfully bridged to an uncomplicated orthotopic heart transplantation on hospital day 130. He was subsequently discharged home on standard post-transplant outpatient medical therapy, and thrives at home.

The explanted heart had increased mass (weight = 107 grams), biatrial dilation, biventricular hypertrophy, and endocardial thickening of both atria as well as the left ventricle (see Figure 2). The wall thicknesses were: right 0.45 cm, left 0.7 cm and interventricular septum 0.7 cm. The ratio of compact to total left ventricular thickness was 0.44. The left ventricle had only rudimentary papillary muscle structures. Histologic sections of right and left ventricles showed features similar to the endomyocardial biopsy along with fibroelastic endocardial thickening, indicating some degree of biventricular disease, although with left-sided predominance. There was no myocyte disarray and the deep endocardial lined recesses were confirmed. Overall, we felt that the pathologic findings in the explanted heart excluded a primary restrictive cardiomyopathy [10]. Given that the patient met established echocardiographic and pathologic criteria [11] for LVNC, our final diagnosis was that of LVNC with restrictive phenotype.

Click to view original image

Figure 2 After cardiac transplantation, the patient’s native heart was sent for pathologic review, which also showed massive left atrial dilation and a heavily trabeculated left ventricular.

In the midst of the patient’s complicated medical course, complete cardiomyopathy workup including coronary imaging, comprehensive metabolic, and neuromuscular testing, which were all non-revelatory. Genetic testing, however, returned positive for a mutation in the MYH7 gene known to be associated with various forms of cardiomyopathy. His defect was specifically in MYH7 (Arg369gln) which is known to be associated with dilated cardiomyopathy and LVNC but has not been reported in restrictive LVNC. There were no variants of unknown significant (VUS) noted on the comprehensive Dilated Cardiomyopathy Panel (Invitae Corporation, San Francisco, CA). His parents were screened for this genetic variant and were negative. Parental screening echocardiograms were also normal.

3. Discussion

Left ventricular noncompaction cardiomyopathy is a rare form of inherited cardiomyopathy that has become of increased interest in the field of pediatric heart failure and cardiomyopathy. Though still not entirely understood, there has been progress made in the past decade as the diagnostic criteria for the disease has been studied and the understanding of the natural history of the disease has improved. Patients with LVNC present with wide variability in symptoms including florid heart failure. In this case, the patient’s initial presentation was to their primary care physician for cough, a common presenting sign in pediatric heart failure.

In parallel with further understanding of the clinical consequences of the disease itself, rapid changes in genetic testing and interest of the heritability of cardiomyopathies has uncovered a number of genetic variants in sarcomeric proteins that lead to all forms of cardiomyopathy, LVNC included. Specific genes for which mutations are known to cause LVNC are MYH7, ACTC, TNNT2, MYBPC3, TMP1, and TNNI3 [12]. LVNC also has phenotypic variability, commonly associated with other forms of cardiomyopathy, and, rarely, restrictive cardiomyopathy. Jefferies and colleagues reported in 2015 that the specific phenotype of LVNC is predictive of survival, though RCM phenotype was too rare (3 cases) to include in the analysis [9].

In this case, our patient was found to have a variant in MYH7 (Arg369Gln). Myosin heavy chain 7 (MYH7) encodes a sarcomeric protein, and mutations within this gene are associated with various forms of cardiomyopathy. Mutations within MYH7, including this mutation, have been reported to be associated with LVNC in patients with and without congenital heart disease [12], but not with a restrictive phenotype [13,14]. The resultant significant cardiomyopathy progressed to severe clinical heart failure. VAD therapy with typical inflow cannulation of the ventricle can be made more difficult in smaller RCM ventricles, with potential for inflow obstruction from non-compacted myocardium in LVNC. In this case, however, the greater left-sided involvement allowed for an anterior approach of the left atrium for the inflow cannula, and this strategy allowed us to bridge to transplant successfully.

4. Conclusions

LVNC is a rare form of heritable cardiomyopathy with wide genotypic variability, numerous phenotypic variations, and a wide spectrum of clinical disease from asymptomatic to end stage heart failure. In this case, we report a genetic variation (MYH7 (Arg369Gln)) associated with LVNC, but not previously linked to the specific phenotype of restrictive LVNC. The clinical presentation of the patient was eventually that of severe heart failure. The patient was able to survive after being supported with a ventricular assist device via atrial cannulation that led to successful cardiac transplantation.


The authors would like to thank the patient’s family for supporting us in sharing this case report. We would also like to thank the Nationwide Children’s Hospital for their support. The authors have no financial relationships relevant to this article or conflicts of interest to disclose. No funding was necessary to complete this manuscript.

Author Contributions

Dr. Morrison and Dr. Nandi conceptualized the case report, drafted the initial manuscript, and reviewed and revised the manuscript.

Dr. Gajarski, Ms. Hodge, Ms. Fitzgerald-Butt, Dr. Baker, and Dr. McConnell reviewed the manuscript for important intellectual material and revised the manuscript.

Competing Interests

The authors have declared that no competing interests exist.


  1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996; 93: 841-842. [CrossRef]
  2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113: 1807-1816. [CrossRef]
  3. Ritter M, Oechslin E, Sütsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997; 72: 26-31. [CrossRef]
  4. Aras D, Tufekcioglu O, Ergun K, Ozeke O, Yildiz A, Topaloglu S, et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail. 2006; 12: 726-733. [CrossRef]
  5. Sandhu R, Finkelhor RS, Gunawardena DR, Bahler RC. Prevalence and characteristics of left ventricular noncompaction in a community hospital cohort of patients with systolic dysfunction. Echocardiography. 2008; 25: 8-12.
  6. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, et al. Clinical characterization of left ventricular noncompaction in children: A relatively common form of cardiomyopathy. Circulation. 2003; 108: 2672-2678. [CrossRef]
  7. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003; 348: 1639-1646. [CrossRef]
  8. Brescia ST, Rossano JW, Pignatelli R, Jefferies JL, Price JF, Decker JA, et al. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation. 2013; 127: 2202-2208. [CrossRef]
  9. Jefferies JL, Wilkinson JD, Sleeper LA, Colan SD, Lu M, Pahl E, et al. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: Results from the pediatric cardiomyopathy registry. J Card Fail. 2015; 21: 877-884. [CrossRef]
  10. Angelini A, Calzolari V, Thiene G, Boffa GM, Valente M, Daliento L, et al. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol. 1997; 80: 1046-1050. [CrossRef]
  11. Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and mechanistic insights into the genetics of cardiomyopathy. J Am Coll Cardiol. 2016; 68: 2871-2886. [CrossRef]
  12. Towbin JA. Inherited cardiomyopathies. Circ J. 2014; 78: 2347-2356. [CrossRef]
  13. Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: Linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007; 28: 2732-2737. [CrossRef]
  14. Dellefave LM, Pytel P, Mewborn S, Mora B, Guris DL, Fedson S, et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet. 2009; 2: 442-449. [CrossRef]
Download PDF
0 0